Systematic Review of Genomic Associations with Blood Pressure and Hypertension in Populations with African-Ancestry

S Singh1,2, J-T Brandenburg1, A Choudhury1

  • 1Sydney Brenner Institute for Molecular Bioscience (SBIMB), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Frontiers in Genetics
|November 8, 2021
PubMed

Insights

This review highlights the under-representation of African-ancestry individuals in genetic studies for hypertension. Developing African cohorts and harmonizing data are crucial for understanding genetic associations with blood pressure traits in these populations.

Area of Science:

  • Genomics
  • Population Genetics
  • Cardiovascular Disease Epidemiology

Background:

  • Hypertension is highly prevalent in individuals of African ancestry.
  • African populations are significantly under-represented in large genome-wide association studies (GWAS).
  • Inclusion of African participants is vital for understanding genetic associations with blood pressure traits.

Purpose of the Study:

  • To critically evaluate existing genetic association studies involving African-ancestry participants.
  • To identify knowledge gaps in genomic research related to blood pressure traits in African populations.
  • To assess the current landscape of genetic discoveries for blood pressure and hypertension in Africans.

Main Methods:

  • Systematic literature review following PRISMA protocol and HuGE Review handbook.
  • Searched for original research in English on genetic association studies for blood pressure traits (systolic/diastolic blood pressure, pulse, mean-arterial pressure, hypertension).
  • Included studies with African-ancestry participants published between January 2007 and April 2020; narrative synthesis was performed.

Main Results:

  • Twelve studies met eligibility criteria; 10 provided genetic association data exclusively from African-ancestry participants.
  • Twenty-six single nucleotide polymorphisms (SNPs) showed genome-wide significance across five blood pressure traits.
  • Six SNPs demonstrated pleiotropic effects (associated with multiple traits), and 12 SNP associations were novel compared to non-African studies.

Conclusions:

  • A significant dearth of genomic association studies exists for African-ancestry populations, particularly within Africa.
  • Methodological variations, small sample sizes, and covariate adjustments limit comparisons and discovery in African studies versus European ones.
  • Establishing African cohorts with harmonized data and African-centric genomic arrays is essential for advancing research, exemplified by initiatives like H3Africa CHAIR.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.7K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.5K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
102
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
172
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
4.9K